# Stemora

> Stemora is a regenerative-medicine company developing a one-step therapy to regenerate native hyaline cartilage and redefine osteoarthritis treatment. Stanford-licensed, FDA 505(b)(2) pathway.

## Pages

- [Home](/): Company overview, science, team, and FAQ.
- [News](/news): Funding, research milestones, and company announcements.

## Optional

- [NSF SBIR Phase I Award](/news/nsf-sbir-phase-i-award): Stemora receives NSF SBIR Phase I award to advance cartilage regeneration technology.